R&D Network Meeting & Workshop: Use of cancer biomarkers in patient treatment – how to standardize molecular testing?


Event Details


PROGRAM

R&D Network Meeting & Workshop:
Use of cancer biomarkers in patient treatment –how to standardize molecular testing?

Organizers: Oslo Cancer Cluster and Akershus University Hospital
Sponsors: Merck and Amgen

Moderator of the day: Tone Ikdahl, Co-Chief Executive Officer, Akershus University Hospital

17:30 – 19:00      Mingling with light refreshments

14:00–14:15 Registration and coffee
14:15–14:20 Welcome and short update from Oslo Cancer Cluster
Ketil Widerberg, General Manager
14:20 – 14:30 Introduction to the topic: Why is ras testing important? Which drugs targeting ras are used in Norway and which are under development? What are the challenges clinicians and patients are facing today regarding ras-testing?
14:30–15:00 International Key Note: Estrid Høgdall, Director of Danish CancerBiobank:
Use of cancer biomarkers in clinical practice and research. Experience from Denmark.
15:00–15:15 The use of RAS-biomarkers in Norwegian cancer treatment
Marianne Grønlie Guren, Oncologist Oslo University Hospital
15:15 –15:30 Pathology Perspective – current practice and challenges
Sonja Steigen, professor and MD at UNN and UiT
15:30–15:45 Case study 
Morten Brændengen, Oncologist at Oslo University Hospital
15:45–15:55 Liquid biopsis – the new way forward
Emiel Janssen, Head of Divison for Quantitive and Molecular Pathology at Stavanger University Hospital
15:55–16:15 Coffee break with cake
16:15-16:30 Introduction to workshop: Best practice from breast cancer
Speaker to be confirmed
16:30–17:00 Workshop in groups
17:00–17:30 Presentations from groups: Wrap up and closing remarks

Print This Post